Page last updated: 2024-08-22

lutetium and Xerostomia

lutetium has been researched along with Xerostomia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Kim, YI; Lee, DY1
Beheshti, A; Bruchertseifer, F; D'Alessandria, C; Eiber, M; Feuerecker, B; Gafita, A; Gschwend, JE; Heck, M; Knorr, K; Kratochwil, C; Morgenstern, A; Pickhard, A; Retz, M; Seidl, C; Tauber, R; Weber, WA1
Bins, A; Braat, A; de Keizer, B; Hunting, J; Krijger, G; Lam, M; Mehra, N; van Kalmthout, L; van Leeuwaarde, R; Ververs, T1

Reviews

1 review(s) available for lutetium and Xerostomia

ArticleYear
Effects of
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:6

    Topics: Actinium; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Leukopenia; Lutetium; Male; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Thrombocytopenia; Treatment Outcome; Xerostomia

2022

Other Studies

2 other study(ies) available for lutetium and Xerostomia

ArticleYear
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
    European urology, 2021, Volume: 79, Issue:3

    Topics: Actinium; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Xerostomia

2021
First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:6

    Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Agents; Dipeptides; Fatigue; Follow-Up Studies; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Middle Aged; Netherlands; Pain; Pain Measurement; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome; Xerostomia

2019